Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fiere

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Infection|January 1, 1992
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia GroupH H Gerhartz, R Marcus, A Delmer, et al.
Leukemia|December 26, 2001
Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year periodX Thomas, C Danaïla, Q H Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)B Coiffier, P A Bryon, F Berger, et al.
Presse Medicale (Paris, France : 1983)|November 29, 1986
[Allogenic bone marrow grafts in acute myeloid leukemias. A retrospective study in 111 grafted patients in first complete remission]D Maraninchi, J P Vernant, E Gluckman, et al.
Bone Marrow Transplantation|July 23, 1998
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationM Michallet, F Persat, N Kranzhöfer, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 21, 1982
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)]D Fiere, H Vuvan, D Guyotat, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
Leukemia & Lymphoma|March 1, 1996
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomasN Vey, D Blaise, P Tiberghien, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Infection|January 1, 1992
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia GroupH H Gerhartz, R Marcus, A Delmer, et al.
Leukemia|December 26, 2001
Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year periodX Thomas, C Danaïla, Q H Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)B Coiffier, P A Bryon, F Berger, et al.
Presse Medicale (Paris, France : 1983)|November 29, 1986
[Allogenic bone marrow grafts in acute myeloid leukemias. A retrospective study in 111 grafted patients in first complete remission]D Maraninchi, J P Vernant, E Gluckman, et al.
Bone Marrow Transplantation|July 23, 1998
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationM Michallet, F Persat, N Kranzhöfer, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 21, 1982
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)]D Fiere, H Vuvan, D Guyotat, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
Leukemia & Lymphoma|March 1, 1996
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomasN Vey, D Blaise, P Tiberghien, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Pageof 14